Filtrona plc
09 February 2006
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
Filtrona plc
2. Name of shareholder having a major interest
FMR CORP and its direct and indirect subsidiaries and Fidelity International
Limited and its direct and indirect subsidiaries
3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18
Non-beneficial interests representing funds under management held on behalf of
clients
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them
Registered Holder Holding
------------------- ---------
Bank of New York Brussels 275,100
JP Morgan, Bournemouth 1,152,604
State Street Bank and Tr Co Lndn 140,900
Brown Brothers Harriman & Co 50
JP Morgan Chase Bank 12,000,000
Bank of New York Europe Ldn 76,150
Citibank London 63,765
JP Morgan, Bournemouth 332,300
Northern Trust, London 369,800
14,410,669
------------
5. Number of shares / amount of stock acquired
N/A
6. Percentage of issued class
N/A
7. Number of shares / amount of stock disposed
1,067,600 shares
8. Percentage of issued class
0.49%
9. Class of security
Ordinary shares
10. Date of transaction
Not advised
11. Date company informed
9 February 2006
12. Total holding following this notification
14,410,669 shares
13. Total percentage holding of issued class following this notification
6.57%
14. Any additional information
N/A
15. Name of contact and telephone number for queries
Shanny Looi - 01908 359 100
16. Name and signature of authorised company official responsible for making
this notification
Jon Green - Company Secretary
Date of notification
9 February 2006
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.